High-Throughput Screening of Surface Engineered Cyanine Nanodots for Active Transport of Therapeutic Antibodies into Solid Tumor

Yating Qin,Guowei Wang,Linying Chen,Yuji Sun,Jiajia Yang,Ying Piao,Youqing Shen,Zhuxian Zhou

DOI: https://doi.org/10.1002/adma.202302292

IF: 29.4

2024-01-01

Advanced Materials

Abstract:The successful delivery of therapeutic biomacromolecules into solid tumor holds great challenge due to their high resistance to penetrate through the complex tumor microenvironments. Here, active-transporting nanoparticles are harnessed to efficiently deliver biomacromolecular drugs into solid tumors through cell transcytosis. A series of molecularly precise cyanine 5-cored polylysine G5 dendrimers (Cy5 nanodots) with different peripheral amino acids (G5-AA) is prepared. The capability of these positively charged nanodots to induce cell endocytosis, exocytosis, and transcytosis is evaluated via fluorescence-based high-throughput screen. The optimized nanodots (G5-R) are conjugated with alpha PD-L1 (a therapeutic monoclonal antibody binding to programmed-death ligand 1) (alpha PD-L1-G5-R) to demonstrate the nanoparticle-mediated tumor active transport. The alpha PD-L1-G5-R can greatly enhance the tumor-penetration capability through adsorption-mediated transcytosis (AMT). The effectiveness of alpha PD-L1-G5-R is tested in treating mice bearing partially resected CT26 tumors, mimicking the local immunotherapy of residual tumors post-surgery in clinic. The alpha PD-L1-G5-R embedded in fibrin gel can efficiently mediate tumor cell transcytosis, and deliver alpha PD-L1 throughout the tumor, thereby enhancing immune checkpoint blockade, reducing tumor recurrence, and significantly prolonging the survival time. The active-transporting nanodots are promising platforms for efficient tumor delivery of therapeutic biomacromolecules. High-throughput fluorescent screening of a library of single-molecule Cy5 nanodots reveals that the nanoparticle-inducing cell transcytosis is highly related to the particles' surface structures and varies significantly with cell lines. The selected Cy5 nanodots with high transcytosis-inducing capability (G5-R) can carry alpha PD-L1 to penetrate deep into solid tumor and generates potent antitumor activity through immune checkpoint blockade therapy.image